Print
Orthopedic Orthotics Market Value to Expand $4,685 Million by 2023

The use of customized orthopedic orthotic devices has increased considerably owing to their advantages such as these are specifically manufactured for a patient as per their measurements which means they are more comfortable than other devices. This in turn is expected to stimulate the market for orthotic devices 

According to a new report published by Allied Market Research, titled, "Orthopedic Orthotics Market by Anatomical region, Posture, Manufacturing: Global Opportunity Analysis and Industry Forecast, 2017-2023," global orthopedic orthotics market was valued at $3,130 million in 2016, and is projected to reach $4,658 million by 2023, growing at a CAGR of 5.8% from 2017 to 2023. Lower-limb orthopedic orthotic devices segment held more than two-fifths share of the total market in 2016.

Orthopedic orthotic devices are used to support the spine or limbs or to assist/prevent relative movements. These devices can be braces, splints or other external devices which is commonly used by patients suffering from orthopedic disorders.

The major factors that contribute to the growth of the market include rise in geriatric population, which is at a higher risk of orthopedic diseases such as osteoporosis, arthritis and sclerosis. Moreover, rise in incidence of accident cases and sports injury in turn stimulates the use of optical fibers. However, the high cost of customized orthotic devices is expected to restrain the market growth.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/2766

Spinal orthopedic orthotic devices segment is expected to witness the highest CAGR of 7.0% during the forecast period. This is primarily attributed to the increasing accident cases which lead to spine injuries. On the other hand, Lower-limb orthopedic orthotic devices generated the maximum revenue, accounting for more than two-fifths share of the global Orthopedic Orthotics Market in 2016.

Key Findings of the Orthopedic Orthotics Market:

Asia-Pacific is projected to grow at the highest CAGR of 6.9% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report include are Bauerfeind AG, Breg, Inc., BSN Medical, DeRoyal Industries, Inc., DJO Global, Ossur, Ottobock, and Truelife, Hanger, Inc., and Fillauer LLC.